Research progress of biomarkers in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis

刘睿超,李乐,王若利,孙金英,王潇,岳红梅
DOI: https://doi.org/10.3760/cma.j.cn131368-20191230-00044
2020-01-01
Abstract:Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by chronic, progressive fibrotic lung lesions.Early diagnosis and treatment of IPF is of great significance for patients with pulmonary fibrosis.Many abnormal biomarkers in IPF can not penetrate the pulmonary endothelial barrier and sometimes their content in plasma can not be detected.Therefore, the sensitive and reliable biomarkers that can reflect lung function and blood and gas barrier injury are used as early diagnosis indicators of pulmonary fibrosis, and to determine the prognosis of the disease, realize the personalized medicine, which has a high value.
What problem does this paper attempt to address?